FDA requests information to explore whether current gluten labeling rules adequately protect consumers, with implications for ...
The U.S. Food and Drug Administration (FDA) is taking active steps to improve disclosure of gluten ingredients in foods.
InvestorsHub on MSN
MannKind shares climb after FDA clears revised Afrezza prescribing label
MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration ...
The agency issued a request for more information that will shape new regulation on ingredient transparency.
Agency is seeking comment from consumers on products.
WASHINGTON — The US Food and Drug Administration has issued a Request for Information (RFI) on labeling and preventing ...
Investing.com -- MannKind Corporation (NASDAQ:MNKD) stock rose 3.5% Monday after the company announced that the U.S. Food and Drug Administration (FDA) approved an update to the prescribing ...
The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...
The U.S. Food and Drug Administration (FDA) started 2025 with new guidance on non-listed food allergens after detailing requirements CPG companies must follow to label the top nine allergens in a ...
Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results